» Articles » PMID: 24899305

Sphingolipid Metabolites in Inflammatory Disease

Overview
Journal Nature
Specialty Science
Date 2014 Jun 6
PMID 24899305
Citations 641
Authors
Affiliations
Soon will be listed here.
Abstract

Sphingolipids are ubiquitous building blocks of eukaryotic cell membranes. Progress in our understanding of sphingolipid metabolism, state-of-the-art sphingolipidomic approaches and animal models have generated a large body of evidence demonstrating that sphingolipid metabolites, particularly ceramide and sphingosine-1-phosphate, are signalling molecules that regulate a diverse range of cellular processes that are important in immunity, inflammation and inflammatory disorders. Recent insights into the molecular mechanisms of action of sphingolipid metabolites and new perspectives on their roles in regulating chronic inflammation have been reported. The knowledge gained in this emerging field will aid in the development of new therapeutic options for inflammatory disorders.

Citing Articles

Association of escitalopram-induced shifts in gut microbiota and sphingolipid metabolism with depression-like behavior in wistar-kyoto rats.

Duan J, Sun J, Ma X, Du P, Dong P, Xue J Transl Psychiatry. 2025; 15(1):54.

PMID: 39962083 PMC: 11833111. DOI: 10.1038/s41398-025-03277-8.


Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome.

Cozzolino K, Sanford L, Hunter S, Molison K, Erickson B, Courvan M Elife. 2025; 13.

PMID: 39928031 PMC: 11810109. DOI: 10.7554/eLife.100197.


Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis.

Zhao F, Shao M, Li M, Li T, Zheng Y, Sun W Cell Mol Biol Lett. 2025; 30(1):18.

PMID: 39920588 PMC: 11804087. DOI: 10.1186/s11658-024-00679-2.


Extracellular vesicles in malaria: proteomics insights, and studies indicate the need for transitioning to natural human infections.

Sima N, Ayllon-Hermida A, Fernandez-Becerra C, Del Portillo H mBio. 2025; 16(3):e0230424.

PMID: 39868784 PMC: 11898581. DOI: 10.1128/mbio.02304-24.


Comprehensive Metabolomics in Mouse Mast Cell Model of Allergic Rhinitis for Profiling, Modulation, Semiquantitative Analysis, and Pathway Analysis.

Patil A, Xu Y Biomolecules. 2025; 15(1).

PMID: 39858503 PMC: 11763337. DOI: 10.3390/biom15010109.


References
1.
Choi J, Gardell S, Herr D, Rivera R, Lee C, Noguchi K . FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci U S A. 2010; 108(2):751-6. PMC: 3021041. DOI: 10.1073/pnas.1014154108. View

2.
Natarajan V, Dudek S, Jacobson J, Moreno-Vinasco L, Huang L, Abassi T . Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. Am J Respir Cell Mol Biol. 2013; 49(1):6-17. PMC: 3727889. DOI: 10.1165/rcmb.2012-0411TR. View

3.
Faroudi M, Hons M, Zachacz A, Dumont C, Lyck R, Stein J . Critical roles for Rac GTPases in T-cell migration to and within lymph nodes. Blood. 2010; 116(25):5536-47. PMC: 3368586. DOI: 10.1182/blood-2010-08-299438. View

4.
Arnon T, Horton R, Grigorova I, Cyster J . Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress. Nature. 2012; 493(7434):684-8. PMC: 3561487. DOI: 10.1038/nature11738. View

5.
Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View